科伦药业：目前公司两条高速生产线，已投入生产

Group 1 - The core point of the article is that Kelun Pharmaceutical (002422) has successfully reduced production costs and improved efficiency through the operation of two high-speed production lines [1] - The company reported a cost reduction of approximately 20% in workshop costs compared to previous levels, indicating enhanced operational efficiency [1]